Shijiazhuang pharmaceutical group Ouyi Pharma Co., Ltd. (OUYI), as a key subsidiary of Shijiazhuang pharmaceutical group corporation, is a comprehensive pharmaceutical manufacture manufacturing API and formulated drugs. The annual revenue amounts to 43 million USD, annual sales 90 million USD and export sales 12 million USD. OUYI was originally founded as Shijiazhuang No. 1 pharmaceutical factory in 1938, after more than 60 year's development, OUYI has developed into a pillar enterprise engaged in R&D, manufacturing and trading. The products from OUYI are currently exported to more than 40 countries and regions including Europe, Africa, South America, South Asia, Taiwan and Japan.
The company product portfolio covers over 300 formulated drugs in terms of tablets, capsules, supporsitories, water injection and powder injection. The annual capacity is 7.5 billion tablets, 1 billion capsules, 300 million capsules, 500 million ampoules and 300 million vials. Huasheng pharmaceutical pharma Co., ltd., as a subsidiary of Ouyi, is mainly engaged in 22 bulk drug manufacturing covering semi-synthetic antibiotics, anti-inflammatory drugs and cardiovascular drugs, the total annual capacity is 400 tons, with the main products of azithromycin, tramadol HCl, cefadroxil and indomethacin at the leading positions in domestic market in terms output and sales volume.
OUYI has well established quality assurance system, and OUYI products comply with USP, BP, EP and JP. In order to enter high-end international market, OUYI is highlighting international certification for both bulk drugs and formulated drugs.